Mometasonfuroaat Vet Mylan (Mometasone Furoate)

Mometasone furoate acts as an agonist at glucocorticoid receptors in skin cells. By binding these receptors, it alters gene expression to suppress pro‑inflammatory cytokines, reduce leukocyte migration, and limit vascular permeability, thereby providing anti‑inflammatory and immunosuppressive effects at the site of application.

The appropriate dose and frequency are determined by the prescribing veterinarian based on the animal’s species, size, severity of the skin condition and the area to be treated. The product is applied topically in a thin layer to the affected skin as directed.

Safety data for use in pregnant or lactating animals are limited. The product should only be used if the potential benefit justifies any potential risk, and this decision must be made by the veterinarian after evaluating the specific situation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometasonfuroaat Vet Mylan contains mometasone furoate, a high‑potency corticosteroid that often provides stronger anti‑inflammatory effects than lower‑potency agents such as hydrocortisone. Compared with other high‑potency steroids, its efficacy is comparable, but formulation differences may affect skin absorption and patient tolerance.

Store Mometasonfuroaat Vet Mylan at room temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture, heat and direct sunlight, and retain it in the original packaging until use.

The product is applied topically to the affected skin area. The veterinarian will instruct the caregiver to spread a thin, even layer over the lesion(s) and to wash hands before and after application to avoid inadvertent exposure.

Serious risks include systemic adrenal suppression with extensive use, severe allergic reactions such as angioedema, skin atrophy or thinning, and secondary infections of the treated area. Any signs of these conditions should prompt immediate veterinary evaluation.

Animals with known hypersensitivity to mometasone furoate or any component of the formulation should not receive the product. It is also contraindicated on infected, ulcerated or open wounds unless directed by a veterinarian, and should be used with caution in young, debilitated or immunocompromised patients.